Home › Compare › HPCRF vs CL

HPCRF vs CL: Dividend Comparison 2026

HPCRF yields 5.05% · CL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HPCRF wins by $84.8K in total portfolio value
10 years
HPCRF
HPCRF
● Live price
5.05%
Share price
$0.20
Annual div
$0.01
5Y div CAGR
32.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112.9K
Annual income
$33,844.32
Full HPCRF calculator →
CL
CL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full CL calculator →

Portfolio growth — HPCRF vs CL

📍 HPCRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHPCRFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HPCRF + CL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HPCRF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HPCRF
Annual income on $10K today (after 15% tax)
$429.40/yr
After 10yr DRIP, annual income (after tax)
$28,767.67/yr
CL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, HPCRF beats the other by $28,003.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HPCRF + CL for your $10,000?

HPCRF: 50%CL: 50%
100% CL50/50100% HPCRF
Portfolio after 10yr
$70.5K
Annual income
$17,371.76/yr
Blended yield
24.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

HPCRF
No analyst data
Altman Z
2.5
Piotroski
6/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+84.9% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HPCRF buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHPCRFCL
Forward yield5.05% ✓4.00%
Annual dividend / share$0.01$2.00 ✓
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR32.5% ✓5%
Portfolio after 10y$112.9K ✓$28.0K
Annual income after 10y$33,844.32 ✓$899.19
Total dividends collected$83.1K ✓$6.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: HPCRF vs CL ($10,000, DRIP)

YearHPCRF PortfolioHPCRF Income/yrCL PortfolioCL Income/yrGap
1← crossover$11,369$669.36$11,120$420.00+$249.00 → HPCRF
2$13,108$942.39$12,357$458.31+$751.00 → HPCRF
3$15,371$1,345.39$13,721$499.76+$1.6K → HPCRF
4$18,400$1,953.64$15,227$544.58+$3.2K → HPCRF
5$22,584$2,896.07$16,885$593.02+$5.7K → HPCRF
6$28,567$4,401.75$18,713$645.34+$9.9K → HPCRF
7$37,461$6,894.69$20,724$701.81+$16.7K → HPCRF
8$51,280$11,196.10$22,938$762.73+$28.3K → HPCRF
9$73,848$18,978.49$25,372$828.41+$48.5K → HPCRF
10$112,861$33,844.32$28,047$899.19+$84.8K → HPCRF

HPCRF vs CL: Complete Analysis 2026

HPCRF — Stock

Home Product Center Public Company Limited operates as a home improvement retailer in Thailand and Malaysia. The company trades in a range of goods and materials for construction, addition, refurbishment, renovation, and improvement of buildings, houses, and residences; and provides a range of related services. It also offers 3D, installation, maintenance, home makeover, warehousing, and distribution services. In addition, the company rents space. As of December 31, 2020, it had 115 branches. The company was founded in 1995 and is headquartered in Nonthaburi, Thailand.

Full HPCRF Calculator →

CL — Consumer Staples

CL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CL shares.

Full CL Calculator →
📬

Get this HPCRF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HPCRF vs SCHDHPCRF vs JEPIHPCRF vs OHPCRF vs KOHPCRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.